Gina Consylman's most recent trade in Assembly Biosciences Inc was a trade of 3,500 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 5, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Assembly Biosciences Inc | Gina Consylman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 3,500 | 3,500 | - | - | Stock Option (right to buy) | |
| Assembly Biosciences Inc | Gina Consylman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2024 | 2,750 | 2,750 | - | - | Stock Option (right to buy) | |
| Assembly Biosciences Inc | Gina Consylman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Assembly Biosciences Inc | Gina Consylman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2022 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Bluebird bio Inc | Gina Consylman | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| Bluebird bio Inc | Gina Consylman | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 25,000 | 125,385 (0%) | 0% | 0 | Common Stock | |
| Bluebird bio Inc | Gina Consylman | Chief Financial Officer | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 170,655 | 170,655 | - | - | Stock Option (right to buy) | |
| Bluebird bio Inc | Gina Consylman | Chief Financial Officer | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 100,385 | 100,385 (0%) | 0% | 0 | Common Stock | |
| Verastem Inc | Gina Consylman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2021 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Assembly Biosciences Inc | Gina Consylman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2021 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| Ironwood Pharmaceuticals I... | Gina Consylman | SVP, CFO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Mar 2021 | 56,372 | 392,616 (0%) | 0% | 0 | Class A Common Stock | |
| Ironwood Pharmaceuticals I... | Gina Consylman | SVP, CFO & Treasurer | Sale of securities on an exchange or to another person at price $ 9.11 per share. | 26 Feb 2021 | 6,980 | 336,244 (0%) | 0% | 9.1 | 63,588 | Class A Common Stock |
| Ironwood Pharmaceuticals I... | Gina Consylman | SVP, CFO & Treasurer | Sale of securities on an exchange or to another person at price $ 9.11 per share. | 26 Feb 2021 | 6,242 | 343,224 (0%) | 0% | 9.1 | 56,865 | Class A Common Stock |
| Ironwood Pharmaceuticals I... | Gina Consylman | SVP, CFO & Treasurer | Sale of securities on an exchange or to another person at price $ 9.11 per share. | 26 Feb 2021 | 2,657 | 351,993 (0%) | 0% | 9.1 | 24,205 | Class A Common Stock |
| Ironwood Pharmaceuticals I... | Gina Consylman | SVP, CFO & Treasurer | Sale of securities on an exchange or to another person at price $ 9.11 per share. | 26 Feb 2021 | 2,527 | 349,466 (0%) | 0% | 9.1 | 23,021 | Class A Common Stock |
| Ironwood Pharmaceuticals I... | Gina Consylman | SVP, CFO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2021 | 84,951 | 354,650 (0%) | 0% | 0 | Class A Common Stock | |
| Assembly Biosciences Inc | Gina Consylman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Oct 2020 | 20,000 | 20,000 | - | - | Stock Option (right to buy) |